Member Info for Odysseus07

that was £0.84p, obviously!!!!) :)

Ouch. That must have been a hit Surfie? £10k 10 years ago?? I had just got my first job after uni 10 years ago and so invested on the new "hot" share tip of FUM (when they were doing R&D in condoms tipped with oil that promoted stronger erections). These were launched but "marketing was wrong". I see from the results that the revenue for FUM last year was £32, 000!!!! Wow ;).... 10 years ago i invested £1000 (i was poor after uni) at about 0.84p. Could be tempted again at about 10-12p..... but would view it as gamble and a bit of fun. Good luck surfie and all

im not wrong Bucolic. Med3000 was the vehicle (not placebo - i know you didnt say that but some peopel call it that who are being unfair). The vehicle is the solution in effect. And vehicles can have an "active" effect. But usually they dont. The question in my mind is: was the phase III trial actually designed well - or could it be another reasons why the vehicle and active arm worked? As normally if there is no difference between the vehicle and the active arm, that the rationale for the treatment is wrong. And the effect is due to another reason )more likely here as by its nature, the trial cant be independently observed between two people in the bedroom). Thats probably why the FDA wants another trial. And why, likley, the EMA will delay/want further data before any approval. Meaning a longer than expected approval and so more capital needed. By the ay, i already own FUM shares from about 10 years ago. It's been "promising" for that many years. Just in case any newbies think the last couple of years are all there is about the company. Its disappointed year after year for 20 years (fact).

hi all, back again. had a few issues with my account. Thanks for the support eatmyshorts.

Looking like it will head to 12p. My new thinking is that i will wait until the new funding is announced. i dont think a partner will be announced before they need tp raise new funds (Nov/Dec). And that will drive share price lower. Plus no update on EMA approval or FDA new trial. This is looking like second half of 2021 before any approval. Its been a disappointing (again) 2020 for FUM after the disappointment of Phase III trial in December 2019 and then the hope of this vehicle, non active Med3000 (after no additional benefit with the actual planned drug). I now will consider buying at between 10-12p, probably early in 2021 - January or so

The absence of any concrete positive news or timings is a negative one by the market - down 5% this morning. Now no moew news until October. So will be largely unchanged / slight shift down until end of October. Meaning many larger investors will jump ship and get better short term gains. No EMEA update, no FDA update. Amd the SP wont "go up in multiples" until the result of the new FDA 6 month trial. So looking like second half of 2021.... meaning larger investors will sell. Remember all, FUM said in Jan 2020 that all would be clear by the Summer / September 2020. So thats why the market has responded in a disappointed way.

Question. An honest question. Why wouldnt potential investors wait until the 6 month FDA new trial is done? or at least only give half the money, rest raised by FUM? It seems a gamble by investors on a trial for a vehicle (not placebo) that has no direct effect. The effect is simply due to evaporation of solvent on the penile tissue........ well.... that is another doubt in my mind..... took 10 years to show the active ingredient was no better than the solvent it was dissolved in.....

Thanks Eatmyshorts for the nice email. GL to you too. Overall my portfolio nest egg is up 5%. Not bad in these times and think i have a good mix that will give growth and dividends when the crises (Brexit and COVID are over). So I'm in for the long term - 2020s.... ready for my retirement in 25 years' time. Assuming i keep my job. Choppy times

im not shorting or doing hedge. Too advanced for me and too risky with such a small stock (for me). I'm just aiming ti buy after the fundraising rights issue - as FUM runs out of money early H2 2021.... and they need to fund a 6 month FDA trial. So will buy after that fund raiser. Of course, this means that I could miss out on a rise on the news announcement on 16th if FUM announce they have a partner and dont need funding and have definite dates for FDA and emea approval

Hi Bucolic. I think eat my shorts was just stating his plans, like i am mine. Im not a deramper. Im just giving my rationale and discussing the future possibilities regarding the SP. I think eat is right 0f no firm news the SP will go down sharply on 16th as some people have loaded up thinking some definite news (a partner, EMA/FDA approval details) will be given. I dont think any detaisl will be given and shares will be sold so money goes elsewhere. I will then buy as ive said when fundraising announced. By the way, i dont wear a white coat, im just a scientific strat guy at a pharma company. And i dont think im pompous. And of course im self interested - i have shares (minimal) from 10 years ago in FUM. We are self interested here - we are hear to make some money based on investments. Let's just chat and discuss and be civil. Its hard time for many right now and ive also been touched by the fall out of COVID.

if you read my post again it will tell you of the timing. Post sept 16th when i have more information. If no partner announced or tighter emea/fda approval timings given, then i will wait for the fund-raising rights isse (probably November time) and buy around that time. That clear enough?

lol "Two solid days of increase". Good grief. "There is none so blind as those who do not see". It hasn't moved (if anything sightly down) since the consensus by people here who call me an idiot, was "high twenties". and "ready for take off". Buying now is a gamble on the results next week on 16th. If no partner announced the SP will decrease sharply,as money runs out Q2 2021. So no partner, rights issue is needed. The share price went up last couple of days as some people are buying as they are gambling on positive news next week.But they cant "know" this as that would be insider dealing and illegal. So buy now and gamble. For me, as i said, i will buy after next week and if no partner, wait for a rights issue and buy at that lower price.

This is a investment discussion forum, so share price and future price is a suitable topic. To get thoughts. No? And the difference between buying at 15p and 10p is massive. In terms of %. Im looking at my rationale and seeing - why buy now before a probable rights issue and diluting in Q4 2020. But I'm seeing if other people have different views based on reason. Or whether they just make personal comments like you. Bucolic by name, bucolic by nature. Byesy bye :)

Down to just above 14p, I see bucolic. I leave it to others to decide who is more "right". No one is spot on. But some, i believe, are more right than others :). My intention is that I will still buy, probably between 10-12p after the SP devaluation in Sept/Oct when more funds are required and the SP offering dilutes the shares/price. No point buying more before that happens

Its bizarre that grown men get so obsessed they are right that they become blind. People, rampers, were saying "high 20s" and "60p minimum". It's actually gone down to 15p. Just look at the facts. To get to mid/high 20s is almost doubling of SP (100% increase). Getting to 12p is about 20% decline. No one is going to get it 100% correct, but who is more right? Are you an idiot bucolic? And when no news on 16th Sept and when approval delays and when more funding required, the SP will go down further. Just the latest funding with selling shares at 8p - if that happens again, the SP will be depressed. Come on, use that brain cell

well. To those people saying "mid twenties at least" and hinting at higher. Looks like i was right. share price staying largely unmoved, gradual decline. Probably to about 10-12p,after no certain news on results si far on Sept 16th. then when this happens i may buy if the vehicle (not placebo) med3000 is looking positive. And after any share decline due to additional funding/dilution as more capital is needed via a rights issue. As FUM runs out of cash (after the Phase III study costs) at about 2021. And i dont think any revenue will be enough not to need a rights issue. And this will mean a SP decline in Sept/Q4 when its announced. Thats my rational-based prediction and position on FUM.

why so quiet on the message board?

fair point. I think 9pis at the very low end. 10-12p is more likely

i am in the pharma industry. EMA dont care about SP sensitive information. It is likely they will just let FUM know that they have been delayed looking at their data and value dossier. Likely - not definite

I have a feeling that EMA will push back approval and so wont be a positive statement until March 2021 and so that will push SP down

no,i said 10-12p. Which will happen if more delays in september.